- Home
- BYRN vs INNV Comparison
BYRN vs INNV Comparison
Compare BYRN & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYRN | INNV |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Nursing Services |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.1M | 485.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BYRN | INNV |
|---|---|---|
| Price | $17.57 | $5.54 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 2 | 2 |
| Target Price | ★ $41.50 | $5.00 |
| AVG Volume (30 Days) | ★ 298.1K | 189.4K |
| Earning Date | 10-09-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 543.53 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | $110,853,000.00 | ★ $884,662,000.00 |
| Revenue This Year | $39.65 | $11.18 |
| Revenue Next Year | $20.62 | $9.58 |
| P/E Ratio | $28.42 | ★ N/A |
| Revenue Growth | ★ 50.99 | 12.48 |
| 52 Week Low | $13.68 | $2.60 |
| 52 Week High | $34.78 | $6.26 |
Technical Indicators
Market Signals| Indicator | BYRN | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 39.60 | 56.94 |
| Support Level | $18.34 | $4.70 |
| Resistance Level | $19.50 | $5.22 |
| Average True Range (ATR) | 0.85 | 0.35 |
| MACD | 0.11 | 0.04 |
| Stochastic Oscillator | 15.68 | 82.21 |
Price Performance
Historical ComparisonAbout BYRN Byrna Technologies Inc.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.